利妥昔单抗治疗干燥综合征合并边缘区淋巴瘤患者后抗心磷脂抗体的标准化。 - Suppr

Suppr

超能文献

Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren's syndrome.

作者信息

Harner K C, Jackson L W, Drabick J J

出版信息

Rheumatology (Oxford). 2004 Oct;43(10):1309-10. doi: 10.1093/rheumatology/keh308.

DOI:10.1093/rheumatology/keh308

PMID:15448217

Abstract

摘要

相似文献

Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren's syndrome.

Rheumatology (Oxford). 2004 Oct;43(10):1309-10. doi: 10.1093/rheumatology/keh308.

Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma.

Arthritis Rheum. 2003 Jun 15;49(3):394-8. doi: 10.1002/art.11109.

[Serum sickness induced by rituximab infusion; report of two cases with hematological malignancies].

Rinsho Ketsueki. 2009 Apr;50(4):304-8.

Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma.

Ann Rheum Dis. 2005 Jun;64(6):958-60. doi: 10.1136/ard.2004.030684. Epub 2004 Dec 2.

[Combination of rituximab with combined pulse-therapy with high doses of methylprednisolone and cyclophosphamide: effects on immunomorphological and functional disturbances of the salivary glands in a patient with Sjogren's disease and MALT-lymphoma].

Ter Arkh. 2008;80(5):76-9.

Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.

Arthritis Rheum. 2005 Sep;52(9):2740-50. doi: 10.1002/art.21260.

[Successful treatment with rituximab in a patient with primary thymic MALT lymphoma complicated with acquired von Willebrand syndrome and Sjögren syndrome].

Rinsho Ketsueki. 2011 Apr;52(4):210-5.

Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis.

Cancer Chemother Pharmacol. 2009 Mar;63(4):759-60. doi: 10.1007/s00280-008-0777-8. Epub 2008 May 24.

Multiple nodular lesions of the chin and oral mucosa in a patient with Sjögren's syndrome.

Eur J Dermatol. 1998 Jul-Aug;8(5):350-2.

[Sjögren's syndrome, lymphoma, cryoglobulinemia].

Rev Prat. 2007 Jun 30;57(12):1287.

引用本文的文献

Splenic Marginal Zone Lymphoma in a Patient With Antiphospholipid Syndrome Treated With Rituximab: A Case Report.

Cureus. 2024 Mar 2;16(3):e55374. doi: 10.7759/cureus.55374. eCollection 2024 Mar.

Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It?

Biomedicines. 2021 Feb 1;9(2):132. doi: 10.3390/biomedicines9020132.

Successful plasma exchange combined with rituximab therapy in aggressive APS-related cutaneous necrosis.

Clin Rheumatol. 2013 Mar;32 Suppl 1:S79-82. doi: 10.1007/s10067-010-1506-3. Epub 2010 Jun 17.

Use of rituximab in the antiphospholipid syndrome.

Curr Rheumatol Rep. 2010 Feb;12(1):40-4. doi: 10.1007/s11926-009-0074-5.

Controversies on rituximab therapy in sjögren syndrome-associated lymphoproliferation.

Int J Rheumatol. 2009;2009:424935. doi: 10.1155/2009/424935. Epub 2010 Jan 28.

Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma.

Open Rheumatol J. 2008;2:38-43. doi: 10.2174/1874312900802010038. Epub 2008 May 28.

Combined therapy with rituximab plus cyclophosphamide/vincristine/prednisone for Sjogren's syndrome-associated B-cell non-Hodgkin's lymphoma.

Clin Rev Allergy Immunol. 2008 Feb;34(1):80-4. doi: 10.1007/s12016-007-8025-2.

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Ann Rheum Dis. 2007 Nov;66 Suppl 3(Suppl 3):iii2-22. doi: 10.1136/ard.2007.081430.

Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome.

Ann Rheum Dis. 2007 Mar;66(3):351-7. doi: 10.1136/ard.2006.057919. Epub 2006 Sep 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验